Saeki Tomoyuki, Mhashilkar Abner, Swanson Xin, Zou-Yang X Helena, Sieger Kerry, Kawabe Shinichiro, Branch Cynthia D, Zumstein Louis, Meyn Raymond E, Roth Jack A, Chada Sunil, Ramesh Rajagopal
Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
Oncogene. 2002 Jul 4;21(29):4558-66. doi: 10.1038/sj.onc.1205553.
Overexpression of the melanoma differentiation associated gene-7 (mda-7) in vitro results in suppression of lung cancer cell proliferation. However, the ability of MDA-7 to suppress lung cancer in vivo has not been previously demonstrated. In this study, we investigated the possibility of inducing overexpression of the mda-7 gene in human non-small cell lung carcinoma cells in vivo and its effects on tumor growth. Adenovirus-mediated overexpression of MDA-7 in p53-wild-type A549 and p53-null H1299 subcutaneous tumors resulted in significant tumor growth inhibition through induction of apoptosis. In addition, decreased CD31/PECAM expression and upregulation of APO2/TRAIL were observed in tumors expressing MDA-7. In vivo studies correlated well with in vitro inhibition of lung tumor cell proliferation and endothelial cell differentiation mediated by Ad-mda7. These data demonstrate that Ad-mda7 functions as a multi-modality anti-cancer agent, possessing both, pro-apoptotic and anti-angiogenic properties. We demonstrate for the first time the potential therapeutic effects of Ad-mda7 in human lung cancer.
黑色素瘤分化相关基因-7(mda-7)在体外的过表达会导致肺癌细胞增殖受到抑制。然而,MDA-7在体内抑制肺癌的能力此前尚未得到证实。在本研究中,我们探讨了在体内诱导人非小细胞肺癌细胞中mda-7基因过表达的可能性及其对肿瘤生长的影响。腺病毒介导的MDA-7在p53野生型A549和p53缺失型H1299皮下肿瘤中的过表达,通过诱导凋亡导致肿瘤生长显著抑制。此外,在表达MDA-7的肿瘤中观察到CD31/PECAM表达降低和APO2/TRAIL上调。体内研究与Ad-mda7介导的体外肺癌细胞增殖抑制和内皮细胞分化情况良好相关。这些数据表明Ad-mda7作为一种多模态抗癌剂,具有促凋亡和抗血管生成特性。我们首次证明了Ad-mda7在人肺癌中的潜在治疗作用。